Mechanism of Action of Nigella sativa on Human Colon Cancer Cells: the Suppression of AP-1 and NF-κB Transcription Factors and the Induction of Cytoprotective Genes

  • Elkady, Ayman I (Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University) ;
  • Hussein, Rania A (Department of Clinical Nutrition, Faculty of Applied Medical Sciences, King Abdulaziz University) ;
  • El-Assouli, Sufian M (Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University)
  • Published : 2015.12.03


Background and Aims: Colorectal cancer is one of the leading causes of death in the world. The aim of this study was to investigate the growth-suppression potentiality of a crude saponin extract (CSENS) prepared from medicinal herb, Nigella sativa, on human colon cancer cells, HCT116. Materials and Methods: HCT116 cells were subjected to increasing doses of CSENS for 24, 48 and 72 h, and then harvested and assayed for cell viability by WST-1. Flow cytometry analyses, cell death detection ELISA, fluorescent stains (Hoechst 33342 and acridine orange/ethidium bromide), DNA laddering and comet assays were carried out to confirm the apoptogenic effects of CSENS. Luciferase reporter gene assays, quantitative reverse transcription-polymerase chain reaction and Western blot analyses were performed to assess the impact of CAERS and CFEZO on the expression levels of key regulatory proteins in HCT116 cells. Results: The results demonstrated that CSENS inhibited proliferation and induced apoptosis. Apoptosis was confirmed by flow cytometry analyses, while CSENS-treated cells exhibited morphological hallmarks of apoptosis including cell shrinkage, irregularity in cellular shape, cellular detachment and chromatin condensation. Biochemical signs of apoptosis, such as DNA degradation, were observed by comet assay and gel electrophoresis. The pro-apoptotic effect of CSENS was caspase-3-independent and associated with increase of the Bax/Bcl-2 ratio. CSENS treatment down-regulated transcriptional and DNA-binding activities of NF-${\kappa}B$ and AP-1 proteins, associated with down-regulation of their target oncogenes, c-Myc, cyclin D1 and survivin. On the other hand, CSENS up-regulated transcriptional and DNA-binding activities of Nrf2 and expression of cytoprotective genes. In addition, CSENS modulated the expression levels of ERK1/2 MAPK, p53 and p21. Conclusions: These findings suggest that CSENS may be a valuable agent for treatment of colon cancer.


Apoptosis;oncogenes;cytoprotective genes;transfection;qRT-PCR;western blot


Supported by : King Abdulaziz City for Science and Technology (KACST)


  1. Aggarwal B, Shishodia S (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Bichemical Pharmacol, 71, 1397-421.
  2. Aggarwal B, Van Kuiken ME, Iyer LH, et al (2009). Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis. Exp Biol Med, 234, 825-49.
  3. Ahmad A, Husain A, Mujeeb M, et al (2013). Review on therapeutic potential of nigella sativa: a miracle herb. Asian Pac J Trop Biomed, 3, 337-52.
  4. Ali BH, Blunden G (2003). Pharmacological and toxicological properties of nigella sativa. Phytother Res, 17, 299-305.
  5. Arber N, Doki Y, Han EK, et al (1997), Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res, 57, 1569-74.
  6. Assim MR, Shahzad M, Yang X, et al (2010). Suppressive effects of black seed oil on ovalbumin induced acute lung remodeling in E3 rats. Swiss Med Wkly, 140, 13128.
  7. Badary OA, Gamal El-Din AM (2001). Inhibitory effects of thymoquinone against 20 methyl cholanthrene induced fibrosarcoma tumorigenesis. Cancer Detect Prev, 25, 362-8.
  8. Badary OA, Al-Shabanah OA, Nagi MN, et al (1999). Inhibition of benzo(a)pyrene induced fore-stomach carcinogenesis in rats by thymoquinone. Eur J Cancer Prev, 8, 435-40.
  9. Banerjee S, Padhye S, Azmi A, et al (2010). Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer, 62, 938-46.
  10. Bellezza I, Mierla AL, Minelli A (2010). Nrf2 and NF-${\kappa}B$ and their concerted modulation in cancer pathogenesis and progression. Cancers, 2, 483-97.
  11. Broker LE, Kruyt, FA, Giaccone G (2005). Cell death independent of caspases: a review. Clin Cancer Res, 11, 3155-62.
  12. Bukholm IK, Nesland JM (2000). Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch, 436, 224-8.
  13. Chakraborty S, Kundu T, Dey S, et al (2006). Tea-induced apoptosis in human leukemia K562 cells as assessed by comet formation. Asian Pac J Cancer Prev, 7, 201-7.
  14. Cipriani B, Borsellino G, Knowles H, et al (2001). Curcumin inhibits activation of $V{\gamma}9V{\delta}2$ T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J Immunol, 167, 3454-62.
  15. Collins AR (2002). Comet assay: principles, applications, and limitations. Methods Mol Biol, 203, 163-177.
  16. Corona G, Deiana M, Incani A, et al (2009). Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1. Mol Nutr Food Res, 53, 897-903.
  17. Debruyne PR, Bruyneel EA, Li X, et al (2001). The role of bile acids in carcinogenesis. Mutat Res, 480-481, 359-69.
  18. Eggler AL, Gay KA, Mesecar AD (2008). Molecular mechanisms of natural products in chemoprevention: Induction of cytoprotective enzymes by Nrf2. Mol Nutr Food Res, 52, 84-94.
  19. Ekholm SV, Reed SI (2000). Regulation of G(1) cyclindependent kinases in the mammalian cell cycle. Curr Opin Cell Biol, 12, 676-84.
  20. Elkady AI, El-Hamidy MS (2013). Induction of growth arrest and apoptosis in human lung cancer cells by crude saponin extract isolated from nigella sativa. Life Science J, 10.
  21. Elkady AI (2013). Crude alkaloid extract of rhazyastricta inhibits proliferation and sensitizes human lung cancer cells to cisplatin through induction of apoptosis. Genet Mol Biol, 36, 12-21.
  22. Elkady AI, Hussein RA, Abu-Zinadah AO (2014). Differential control of growth, apoptotic activity and gene expression in human colon cancer cells by extracts derived from medicinal herbs, rhazya stricta and zingiber officinale and their combination. World J Gastroenterol, 20, 15275-88.
  23. Fang JY, Richardson BC (2005). The MAPK signaling pathways and colorectal cancer. Lancet Oncol, 6, 322-7.
  24. Fulda S, Debatin KM (2004). Targeting apoptosis pathways in cancer therapy. Curr Cancer Drug Targets, 4, 569-76.
  25. Ganan-Gomez I, Wei Y, Yang H, et al (2013). Oncogenic functions of the transcription factor Nrf2. Free Radical Biol Med, 65, 750-64.
  26. Gali-Muhtasib H, Roessner A, Schneider-Stock R (2006). Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol, 38, 1249-53.
  27. Gao JL, Lv GY, He BC, et al (2013). Ginsengsaponin metabolite 20 (S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways. Oncol Rep, 30, 292-8.
  28. Glinghammer HI, Rafter JJ (2002). Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promotor activity and the transcription factor NF-${\kappa}B$ and AP-1. Carcinogenesis, 23, 839-45.
  29. Gopalakrishnan A, Kong AT (2008). Anticarcinogenesis by dietary phytochemicals: Cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-${\kappa}B$ and AP-1 in abnormal cancer cells. Food Chemical Toxicol, 46, 1257-70.
  30. Guclu-Ustundag O, Mazza G (2007). Saponins: Properties, Applications and Processing. Critical Rev Food Science Nutrit, 47, 231-58.
  31. Gurfinkel M, Rao AV (2003). Soya saponins: the relationship between chemical structure and colon anticarcinogenic activity. Nutr Cancer, 47, 24-33.
  32. Han W, Li L, Qiu S, et al (2007). Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther, 6, 1641-9.
  33. Hainaut P, Wiman KG (2009). 30 years and a long way into p53 research. Lancet Oncol, 10, 913-9.
  34. Hess J, Angel P, Schorpp-Kistner M (2004). AP-1 subunits: quarrel and harmony among siblings. J Cell Sci, 117, 5965-73.
  35. Hogan FS, Krishnegowda NK, Mikhailova M, et al (2007). Flavonoid, silibinin, inhibits proliferation and promotes cellcycle arrest of human colon cancer. J Surg Res, 143, 58-65.
  36. Hsu TC, Young MR, Cmarik J, et al (2000). Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free RadicBiol Med, 28, 1338-48.
  37. Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300.
  38. Karim BO, Rhee KJ, Liu G, et al (2013). Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc(-/+) mice. BMC Cancer, 13, 157.
  39. Khader M, Bresgen N, Eckl PM (2009). In vitro toxicological properties of thymoquinone. Food Chem Toxicol, 47, 129-33.
  40. Khan N, Afaq F, Mukhtar H (2006). Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis, 28, 233-9.
  41. Khan A, Chen H-C, Tania M, et al (2011). Anticancer activities of Nigella sativa (black cumin). Afr J Tradit Complement Alter. Afr J Tradit Complement Altern Med, 8, 226-32.
  42. Kim H, You S, Kong B, et al (2001). Necrotic cell death by hydrogen peroxide in immortal DF-1 chicken embryo fibroblast cells expressing deregulated MnSOD and catalase. Biochimca et Biophysica Acta, 1540, 137-46.
  43. Kirilova M, Ivanov R, Miloshev GA (2005). Novel Parameter In Comet Assay Measurements. Genetika, 37, 93-101.
  44. Kouraklis G, Theocharis S, Vamvakas P, et al (2006). Cyclin D1 and Rb protein expression and their correlation with prognosis in patients with colon cancer. World J Surg Oncol, 4, 5.
  45. Kundu JK, Surh YJ (2004). Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res, 555, 65-80.
  46. Lavoie JN, L'Allemain G, Brunet A, et al (1996). Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem, 271, 20608-16.
  47. Lee J-M, Johnson JA (2004). An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Molecular Biol, 37, 139-43.
  48. Lee SY, Munerol B, Pollard S, et al (2006). The reaction of flavanols with nitrous acid protects against nitrosamine formation and leads to the formation of nitroso derivatives which inhibit cancer cell growth, Free RadicBiol Med, 40, 323-34.
  49. Li XL, Zhou J, Chen ZR, et al (2015). p53 mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivation. World J Gastroenterol, 21, 84-93.
  50. Lind DS, Hochwald SN, Malaty J, et al (2001). Nuclear factor-${\kappa}B$ is upregulated in colorectal cancer. Surgery, 130, 363-9.
  51. Lu G, Liao J, Yang G, et al (2006). Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res, 66, 11494-501.
  52. Macdonald JS, Astrow AB (2001). Adjuvant therapy of colon cancer. Semin Oncol, 28, 30-40.
  53. Man S, Gao W, Zhang Y, et al (2010). Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia, 81, 703-14.
  54. Martin KR (2006). Targeting Apoptosis with Dietary Bioactive Agents. Exp Biol Med, 231, 117-29.
  55. Nagata S (2000). Apoptotic DNA fragmentation. Exp Cell Res, 256, 12-8.
  56. Oren M, Rotter V (2010). Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol, 2, 1107.
  57. Pearson G, Robinson F, Beers GT, et al (2001). Mitogenactivated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev, 22, 153-83.
  58. Pereira SG, Oakley F (2008). Nuclear factor-${\kappa}B$1: Regulation and function. Int J Biochem Cell Biol, 40, 1425-30.
  59. Prouillet C, Maziere JC, Maziere C, et al (2004). Stimulatory effect of naturally occurring flavonolsquercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol, 67, 1307-13.
  60. Rabik CA, Dolan ME (2007). Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev, 33, 9-23.
  61. Samejima K, Tone S, Kottke TJ, et al (1998). Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution. J Cell Biol, 143, 225-39.
  62. Schulz, WA. Molecular biology of human cancers: an advanced student's textbook. Springer Science & Business Media, 2005. Springer Dordrecht, Netherlands.
  63. Seeram NP, Adams LS, Hardy ML, et al (2004). Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem, 52, 2512-7.
  64. Seeram NP, Adams LS, Henning SM, et al (2006). In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem, 16, 360-7.
  65. Shan BE, Wang MX, Li RQ (2009). Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest, 27, 604-612.
  66. Su CC, Chen GW, Lin LG, et al (2006). Curcumin inhibits cell migration of human colon cancer colo-205 cells through the inhibition of nuclear factor kappaB/p65 and downregulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res, 26, 1281-8.
  67. Sun X, Li Y, Li W, et al (2006). Selective induction of necrotic cell death in cancer cells by beta-lapachone through activation of DNA damage response pathway. Cell Cycle, 5, 2029-35.
  68. Surh YJ, Kundu JK, Na HK (2008). Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med, 74, 1526-39.
  69. Susin SA, Daugas E, Ravagnan L, et al (2000). Two distinct pathways leading to nuclear apoptosis. J Exp Med, 192, 571-80.
  70. Trease GE, Evans WC (2002). Pharmcognosy, Editition 16, Saunder Elsevier, London, 135-47.
  71. Vaiopoulos G, Papachroni K, Papavassiliou AG (2010). Colon carcinogenesis: Learning from NF-${\kappa}B$ and AP-1. Int J Biochem Cell Biol, 42, 1061-5.
  72. Vermeulen K, Van Bockstaele DR, Berneman ZN (2003). The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif, 36, 131-49.
  73. Wong RS (2011). Apoptosis in cancer: from pathogenesis to Treatment. J Exp Clin Cancer Res, 30, 87.
  74. Wright JH, Munar E, Jameson DR, et al (1999). Mitogenactivated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci USA, 96, 11335-40.
  75. Wruck CJ, Claussen M, Fuhrmann G, et al., (2007). Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway. J Neural Transm Suppl, 72, 57-67.
  76. Yang SY, Sales KM, Fuller B, et al (2009). Apoptosis and colorectal cancer: implications for therapy. Trends Mol Med, 15, 225-33.
  77. Yasuhara S, Zhu Y, Matsui T, et al (2003). Comparison of comet assay, electro nmicroscopy, and flow cytometry for detection of apoptosis. J Histochem Cytochem, 51, 873-85.
  78. Yun J-M, Afaq F, Khan N, et al (2009). Delphinidin, an anthocyanidin in pigmented fruits and vegetables, induces apoptosis and cell cycle arrest in human colon cancer HCT116 cells. Molecular Carcinogenesis, 48, 260-70.
  79. Yu X, Kensler T (2005). Nrf2 as a target for cancer chemoprevention. Mutat Res, 591, 93-102.
  80. Zhou H, Xu M, Gao Y, et al (2014). Matrine induces caspaseindependent programcell death in hepatocellular carcinoma through bid-mediated nuclear translocation of apoptosis inducing factor. Molecular Cancer, 13, 59.

Cited by

  1. Harmal Extract Induces Apoptosis of HCT116 Human Colon Cancer Cells, Mediated by Inhibition of Nuclear Factor-κB and Activator Protein-1 Signaling Pathways and Induction of Cytoprotective Genes vol.17, pp.4, 2016,
  2. Effective Medicinal Plant in Cancer Treatment, Part 2 pp.2156-5899, 2017,